Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. Mar-Apr 2012;30(2):410-8.
doi: 10.1016/j.biotechadv.2011.07.015. Epub 2011 Aug 3.

Post-translational Modification of Plant-Made Foreign Proteins; Glycosylation and Beyond


Post-translational Modification of Plant-Made Foreign Proteins; Glycosylation and Beyond

Diane E Webster et al. Biotechnol Adv. .


The complex and diverse nature of the post-translational modification (PTM) of proteins represents an efficient and cost-effective mechanism for the exponential diversification of the genome. PTMs have been shown to affect almost every aspect of protein activity, including function, localisation, stability, and dynamic interactions with other molecules. Although many PTMs are evolutionarily conserved there are also important kingdom-specific modifications which should be considered when expressing recombinant proteins. Plants are gaining increasing acceptance as an expression system for recombinant proteins, particularly where eukaryotic-like PTMs are required. Glycosylation is the most extensively studied PTM of plant-made recombinant proteins. However, other types of protein processing and modification also occur which are important for the production of high quality recombinant protein, such as hydroxylation and lipidation. Plant and/or protein engineering approaches offer many opportunities to exploit PTM pathways allowing the molecular farmer to produce a humanised product with modifications functionally similar or identical to the native protein. Indeed, plants have demonstrated a high degree of tolerance to changes in PTM pathways allowing recombinant proteins to be modified in a specific and controlled manner, frequently resulting in a homogeneity of product which is currently unrivalled by alternative expression platforms. Whether a recombinant protein is intended for use as a scientific reagent, a cosmetic additive or as a pharmaceutical, PTMs through their presence and complexity, offer an extensive range of options for the rational design of humanised (biosimilar), enhanced (biobetter) or novel products.

Similar articles

See all similar articles

Cited by 18 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources